Platelets and cytokines: How and why? (Q38017397)

27 August 2017

Platelets and cytokines: How and why? (English)

1 reference

27 August 2017

O Garraud

1

1 reference

PubMed ID

22682309

27 August 2017

H Hamzeh-Cognasse

series ordinal

2

1 reference

PubMed ID

22682309

27 August 2017

F Cognasse

series ordinal

3

1 reference

27 August 2017

7 June 2012

1 reference

Transfusion Clinique et Biologique

27 August 2017

1 reference

27 August 2017

19

1 reference

27 August 2017

3

1 reference

27 August 2017

104-108

1 reference

Platelets and the immune continuum

27 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

New strategies for the optimal use of platelet transfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelet transfusion: products, indications, dose, threshold and efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

The role of the plasma from platelet concentrates in transfusion reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

7 January 2021

Platelet transfusions

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelet Toll-like receptor expression: the link between "danger" ligands and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Pathogen sensing, subsequent signalling, and signalosome in human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

The platelet as an immune cell-CD40 ligand and transfusion immunomodulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

[Platelets cytokines and their effects on platelet transfusion].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelet immunology and the immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelet alpha-granules: basic biology and clinical correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelets as central mediators of systemic inflammatory responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelets: physiology and biochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelet physiology and thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Clinical relevance of microparticles from platelets and megakaryocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Cytokine generation in stored platelet concentrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelet genomics and proteomics in human health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelet storage lesion: a new understanding from a proteomic perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Proteomics meets blood banking: identification of protein targets for the improvement of platelet quality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

The platelet storage lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Release of potential immunomodulatory factors during platelet storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Deciphering the human platelet sheddome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Determinants of ABH expression on human blood platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

The causes and treatment of reactions to platelet transfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

In vitro assessment of apheresis and pooled buffy coat platelet components suspended in plasma and SSP+ photochemically treated with amotosalen and UVA for pathogen inactivation (INTERCEPT Blood System™)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

The interaction of bacterial pathogens with platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

7 January 2021

Platelets and pathogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelets in defense against bacterial pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

[Platelets "Toll-like receptor" engagement stimulates the release of immunomodulating molecules]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Evidence of Toll-like receptor molecules on human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Expression of Toll-like receptors on human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Efficient phagocytosis of periodontopathogens by neutrophils requires plasma factors, platelets and TLR2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Invasive Streptococcus pneumoniae trigger platelet activation via Toll-like receptor 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Toll-like receptor 2 stimulation of platelets is mediated by purinergic P2X1-dependent Ca2+ mobilisation, cyclooxygenase and purinergic P2Y1 and P2Y12 receptor activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Aggregation and microparticle production through toll-like receptor 4 activation in platelets from recently menopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Lipopolysaccharide is a direct agonist for platelet RNA splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Increased levels of soluble CD40L in African tick bite fever: possible involvement of TLRs in the pathogenic interaction between Rickettsia africae, endothelial cells, and platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelets express functional Toll-like receptor-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1β-rich microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Toll-like receptor 4 signal transduction in platelets: novel pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelet Ca(2+) responses coupled to glycoprotein VI and Toll-like receptors persist in the presence of endothelial-derived inhibitors: roles for secondary activation of P2X1 receptors and release from intracellular Ca(2+) stores

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Demonstration of an activation regulated NF-kappaB/I-kappaBalpha complex in human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelets and megakaryocytes contain functional nuclear factor-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Nuclear emancipation: a platelet tour de force

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

The Feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-κB inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Platelet-derived CD40L (CD154) mediates neutrophil upregulation of Mac-1 and recruitment in septic lung injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Human platelets can activate peripheral blood B cells and increase production of immunoglobulins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Analysis of serum soluble CD40 ligand (sCD40L) in the patients undergoing allogeneic stem cell transplantation: platelet is a major source of serum sCD40L

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

The role of CD40 in CD40L- and antibody-mediated platelet activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

CD40 ligand influences platelet release of reactive oxygen intermediates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

Soluble CD40 ligand induces β 3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40–CD40L signalling in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRACLI.2012.02.004

10.1016/J.TRACLI.2012.02.004

7 January 2021

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

22682309